Oncology for the Inquisitive Mind

By: Michael Fernando and Josh Hurwitz
  • Summary

  • Cancer is a fascinating but rapidly evolving discipline - it's a full-time job just keeping up to date. In this podcast, Dr Michael Fernando and Dr Joshua Hurwitz explore the latest trials, research, and practice-changing updates, as well as regular interviews with renowned oncology specialists. Ideal for those starting their training journey, established specialists and anyone interested in medical science, oncological practice, or terrible jokes. Preferably all three.

    Hosted on Acast. See acast.com/privacy for more information.

    Michael Fernando and Josh Hurwitz
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • 137. Back to Basics - High Risk Breast Cancer
    Nov 23 2024

    Breast Cancer is complex, as are the treatment options that clinicians and patients must traverse. Stage III breast cancer has up to a 57% chance of recurring up to 20 years after diagnosis. Josh and Michael look at one of the practice-changing papers that tried to address how to manage high-risk patients. This study is called Soft and Text. It asked if adding ovarian suppression to aromatase inhibitors was better than ovarian suppression with selective estrogen receptor modulators (SERMs) to reduce the risk of recurrence in premenopausal women.


    Studies discussed in the episode:

    SOFT and TEXT


    For more episodes, resources and blog posts, visit www.inquisitiveonc.com

    Please find us on Twitter @InquisitiveOnc!

    If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com


    Art courtesy of Taryn Silver

    Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/


    Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.


    Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have no editorial rights or early previews, and they have access to the episode at the same time you do.


    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    27 mins
  • 136. Evolving landscape of Genitourinary Cancers (Bladder Cancer) - Prof Enrique Grande
    Nov 16 2024

    Prof Enrique Grande, a medical oncologist from Madrid, Spain, is our guest on Oncology for the Inquisitive Mind this week. Enrique is not your average oncologist nor your average podcast guest with a fascinating back story, a varied career and the charisma and wisdom to match!


    Enrique has worked in all facets of oncology, including industry and is helping transform how patients access oncology care in Spain. He is the director of the Medical Oncology Program and Clinical Research Lead at the MD Anderson Centre Madrid. Prof Grande strongly focused on genitourinary and endocrine cancer research and was awarded his PhD in pharmacokinetic and pharmacodynamics study of tyrosine kinase inhibitors in liver metabolism.


    Listen on, and you will learn all there is to know about bladder cancer and the world of medical oncology.


    We explore the #NIAGARA trial, #EV302 and many other trials that are changing the face of bladder cancer!


    For more episodes, resources and blog posts, visit www.inquisitiveonc.com

    Please find us on Twitter @InquisitiveOnc!

    If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com


    Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have no editorial rights or early previews, and they have access to the episode at the same time you do.


    Art courtesy of Taryn Silver

    Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/

    Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.


    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    39 mins
  • 135. ESMO 2024 - Breast Cancer with Dr Adam Brufsky
    Nov 9 2024

    In our final ESMO 2024 analysis this week, we bring back Dr. Adam Brufsky, "a giant among men (and women)" in breast cancer research and management. He discusses the field, the pivotal updates in ESMO, and what this means for patients. He also explores many of the unanswered questions.


    Links to studies discussed in this episode (subscription may be required):

    DESTINYBREAST012

    KEYNOTE522


    Many other pearls of wisdom - so tune in!


    For more episodes, resources and blog posts, visit www.inquisitiveonc.com

    Please find us on Twitter @InquisitiveOnc!

    If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com


    Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have no editorial rights or early previews, and they have access to the episode at the same time you do.


    Art courtesy of Taryn Silver

    Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/

    Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.



    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    28 mins

What listeners say about Oncology for the Inquisitive Mind

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.